These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH. Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924 [Abstract] [Full Text] [Related]
3. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA. Tumour Biol; 2016 Sep 15; 37(9):12273-12286. PubMed ID: 27271989 [Abstract] [Full Text] [Related]
4. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Aly DM, Gohar NA, Abd El-Hady AA, Khairy M, Abdullatif MM. Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):555-562. PubMed ID: 32102538 [Abstract] [Full Text] [Related]
5. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Mourad L, El-Ahwany E, Zoheiry M, Abu-Taleb H, Hassan M, Ouf A, Rahim AA, Hassanien M, Zada S. Cancer Biol Ther; 2018 May 04; 19(5):400-406. PubMed ID: 29333940 [Abstract] [Full Text] [Related]
6. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Motawi TM, Sadik NA, Shaker OG, Ghaleb MH. Tumour Biol; 2016 Jul 04; 37(7):9865-74. PubMed ID: 26812693 [Abstract] [Full Text] [Related]
7. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F, Lu Z, Chen B, Dong P, Zheng J. Diagn Pathol; 2015 Jul 28; 10():129. PubMed ID: 26215970 [Abstract] [Full Text] [Related]
8. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS, Elgendy NA, Tawfik NA, Elnasser AM. Egypt J Immunol; 2019 Jul 28; 26(2):31-40. PubMed ID: 31926493 [Abstract] [Full Text] [Related]
11. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. Elemeery MN, Badr AN, Mohamed MA, Ghareeb DA. World J Gastroenterol; 2017 Jun 07; 23(21):3864-3875. PubMed ID: 28638226 [Abstract] [Full Text] [Related]
13. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Rashad NM, El-Shal AS, Shalaby SM, Mohamed SY. Mol Cell Biochem; 2018 Oct 07; 447(1-2):125-136. PubMed ID: 29455432 [Abstract] [Full Text] [Related]
14. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Wu J, Wu Y, Luo Y, Li X, Lin N, Yang X, Lin Y, Chen M. Ann Clin Lab Sci; 2020 Mar 07; 50(2):219-227. PubMed ID: 32366560 [Abstract] [Full Text] [Related]
15. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N. Cancer Biomark; 2019 Mar 07; 26(4):501-512. PubMed ID: 31658041 [Abstract] [Full Text] [Related]
17. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L, Xu Q, Xie H, Gu G, Jiang J. Clin Transl Oncol; 2016 Aug 07; 18(8):841-7. PubMed ID: 26586116 [Abstract] [Full Text] [Related]
18. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM. Lancet Oncol; 2015 Jul 07; 16(7):804-15. PubMed ID: 26088272 [Abstract] [Full Text] [Related]
19. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma. Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y, Zhang N, Guo H. Tumour Biol; 2016 May 07; 37(5):6539-49. PubMed ID: 26637228 [Abstract] [Full Text] [Related]
20. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma. Zhuang C, Jiang W, Huang D, Xu L, Yang Q, Zheng L, Wang X, Hu L. Clin Res Hepatol Gastroenterol; 2016 Sep 07; 40(4):386-96. PubMed ID: 26669589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]